Bit Pulls Back Toward Key Support 20260403 1 Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges Legacy Education Inc LGCY Q1 2026 Earnings Strong EPS Beat Despite Revenue Headwinds and Stock Pullback BillionToOne BLLN Q1 2026 Earnings Strong EPS Beat Overshadows Missing Revenue Details Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Century Aluminum Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction